169360 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors Cardioregulators, e.g. antihypotensives, antiarrhythmics
IMMUNOCHROMATOGRAPHIC TEST STRIP FOR DETECTING DIGOXIN AND USES THEREOF
#2Eplerenone for phenotyping of CYP3A5 enzyme activity in saliva samples
#3TARGET MODIFICATION FOR TRACKING AND DETECTION
#4Composition, device, and method for detecting olmesartan and improving compliance in treating hypertension
#5MICROFLUIDIC ANALYTE DETECTION CARTRIDGE DEVICE, SYSTEM AND METHOD
#6METHODS FOR OLMESARTAN DOSING BY AUC
#7METHODS OF TREATMENT OF CARDIAC ARRHYTHMIAS USING VANOXERINE AND MODIFICATION OF DIET
#8RFamide-related peptides and methods thereof
#9Methods for determining ligand binding to a target protein using a thermal shift assay
#10Methods for determining ligand binding to a target protein using a thermal shift assay
#11Methods for detecting sulfhydryl-containing compounds in a biological test sample
#12METHOD FOR IDENTIFYING A SUBJECT AT RISK OF DEVELOPING HEART FAILURE BY DETERMINING THE LEVEL OF GALECTIN-3 OR THROMBOSPONDIN-2
#13PHENOXYBENZAMINE ASSAY
#14Lenalidomide and thalidomide immunoassays
#15Lenalidomide and thalidomide immunoassays
#16Lenalidomide and thalidomide immunoassays
#17METHOD FOR DETERMINATION OF MARINOBUFAGENIN LEVELS AND COMPOUNDS EMPLOYABLE IN SUCH METHOD
#18Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
#19Method for Examination of Alzheimer's Disease
#20SYNTHESIS AND PHARMACOKINETIC ACTIVITIES OF PULMODIL AND PULMODIL-1, TWO CHLOROPHENYLPIPERAZINE SALT DERIVATIVES
#21METHODS OF DETERMINING ACTIVE LEVELS OF DRUGS IN FLUID SAMPLES
#22Detection of blood plasma amygdalin of dissipating blood stasis botanical
#23Methods for detecting sulfhydryl-containing compounds in a biological test sample
#24Detection of blood plasma schizadrin B of dissipating blood stasis botanical
#25Detection of blood plasma Danshensu and Salvianolic acid B dissipating blood stasis botanical
#26B-Blocker Pharmacogenetics in Heart Failure
#27Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
#28METHODS OF DETERMINING ACTIVE LEVELS OF DRUGS IN FLUID SAMPLES
#29Methods for determining and lowering caffeine concentration in fluids
#30Conjugates of mycophenolic acid
#31Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus
#32Method of modulating the activity of calcium channels in cardiac cells and reagents therefor
#33Conjugates of mycophenolic acid